Business Description
Bonus BioGroup Ltd
ISIN : IL0004850116
Compare
Compare
Traded in other countries / regions
BONS.IsraelBBIXF.USA IPO Date
2019-07-29Description
Bonus BioGroup Ltd is a biotechnology company. It generates viable tissue-regenerating bone grafts. The company treats skeletal disorders such as bone- and cartilage-related arthritis and various types of bone and joint trauma. It is in the field of tissue engineering, human adipose tissue-derived cells and live bone transplantation.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.32 | |||||
| Equity-to-Asset | 0.48 | |||||
| Debt-to-Equity | 0.7 | |||||
| Debt-to-EBITDA | -0.42 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 8.4 | |||||
| 3-Year EPS without NRI Growth Rate | 3.1 | |||||
| 3-Year FCF Growth Rate | -2.4 | |||||
| 3-Year Book Growth Rate | -6.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.76 | |||||
| 9-Day RSI | 23.64 | |||||
| 14-Day RSI | 23.05 | |||||
| 6-1 Month Momentum % | 8233.33 | |||||
| 12-1 Month Momentum % | 150 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.95 | |||||
| Quick Ratio | 1.95 | |||||
| Cash Ratio | 1.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -5.3 | |||||
| Shareholder Yield % | 0.57 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -99.61 | |||||
| ROA % | -64.31 | |||||
| ROIC % | -135.77 | |||||
| 3-Year ROIIC % | 146.3 | |||||
| ROC (Joel Greenblatt) % | -143.25 | |||||
| ROCE % | -72.81 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 9.23 | |||||
| EV-to-EBIT | -4.82 | |||||
| EV-to-EBITDA | -5.34 | |||||
| EV-to-FCF | -5.79 | |||||
| Earnings Yield (Greenblatt) % | -20.75 | |||||
| FCF Yield % | -16.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BBIXF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bonus BioGroup Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.011 | ||
| Beta | 72.46 | ||
| Volatility % | 190.26 | ||
| 14-Day RSI | 23.05 | ||
| 14-Day ATR ($) | 0.00056 | ||
| 20-Day SMA ($) | 0.02225 | ||
| 12-1 Month Momentum % | 150 | ||
| 52-Week Range ($) | 0.0003 - 0.055 | ||
| Shares Outstanding (Mil) | 1,167.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bonus BioGroup Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bonus BioGroup Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bonus BioGroup Ltd Frequently Asked Questions
What is Bonus BioGroup Ltd(BBIXF)'s stock price today?
The current price of BBIXF is $0.02. The 52 week high of BBIXF is $0.06 and 52 week low is $0.00.
When is next earnings date of Bonus BioGroup Ltd(BBIXF)?
The next earnings date of Bonus BioGroup Ltd(BBIXF) is .
Does Bonus BioGroup Ltd(BBIXF) pay dividends? If so, how much?
Bonus BioGroup Ltd(BBIXF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers